Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- Important Deadline Approaches for iRobot Corporation Lawsuit
- Biohaven Ltd Investors Encouraged to Act Before Class Action Deadline
- Silvaco Welcomes New CEO: A New Era of Innovation Ahead
- Exciting Developments Ahead: Nvidia's Tech Innovations Unveiled
- Hims & Hers Health, Inc. Faces Class Action: Key Dates Ahead
- Debunking the Myths of Climate Damage and Economic Impact
- Korea Post Takes Action Amid US Customs Policy Changes
- Ark Invest Shifts Portfolio: Major Moves with Robinhood and Shopify
- EpicQuest Education Reports Impressive Growth and Recovery
- KT&G's Dividend Growth Strategy and Share Repurchase Program
- Join the Centene Corporation Securities Class Action Today
- Transforming Industries with Zilliz Cloud's AI Agents Today
- Tencent Cloud and Voodoo Unite to Enhance Mobile Game Quality
- KT&G Plans Increased Dividends with Share Repurchase Strategy
- Leadership Change at Silvaco: A New Era Begins
- Cryptocurrency Market Update: Large Investors Accumulate BTC Amid Fluctuations
- WethosAI Launches Revolutionary Aii™ for Enhanced Business Agility
- Investors Urged to Join Designer Brands Class Action Lawsuit
- National Grid plc Investors: Important Class Action Insights
- Growing Ceramic Tiles Market: Trends, Challenges, and Insights
- Important Legal Update for Sarepta Therapeutics Investors
- Exploring Future Trends in the Ceramic Tiles Market Growth
- Key Developments in 5 Prominent Stocks Capturing Attention
- RxSight Securities Fraud Case: Investor Opportunities and Actions
- Investors Prepare for Legal Action Against Sable Offshore Corp.
- Yeelight to Unveil Innovative Smart Lighting at IFA
- KBR, Inc. Faces Lawsuit Over Allegations of Misleading Info
- Petco's Investors Urged to Act Before Class Action Deadline
- Bravo Mining Corp. Takes Major Steps with Economic Assessment
- Exciting Flagship Opening of H&M at Iconic Market Location
- Alkane’s Financial Triumph: A$33 Million Profit and Future Growth
- Legal Firm Urges Western Asset Management Investors to Respond
- Alkane Resources Reports A$33 Million Profit for FY2025
- Major Growth in the Wire & Cable Market Projected for 2029
- Important Fiserv Class Action: Investors Urged to Act Now
- Miata Metals Raises $5.5 Million in Successful Placement
- Wire & Cable Market Projected Growth Amid Renewable Energy Boom
- Miata Metals Secures $5.5 Million in Private Placement Funding
- Timely Action for Investors in Easterly ROCMuni Bond Fund
- Important Steps for Alto Neuroscience, Inc. Investor Action
- Coty Inc. Faces Securities Investigation – Key Details Inside
- Understanding the Class Action Lawsuit Filed Against PubMatic
- Kevin O'Leary Discusses Powell's Tough Stance on Rate Cuts Amid AI Growth
- Flywire Corporation Investors Urged to Act Before Deadline
- Centene Corporation Investors: Important Class Action Updates
- Market Dynamics: CoreWeave Sees Insider Selling Amid Buying Surge
- Open.Video: The Rising Alternative for Video Creators
- When to Trade GBP/USD for the Best Returns
- Projected Surge in the Global Pressure Vessels Market Growth
- Exploring the Growth of the Global Pressure Vessels Market